Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Balchem Corp Market Cap
The Balchem Corp (BCPC) share price is expected to increase by 5.44% over the next year. This is based on calculating the average 12-month share price estimate provided by 2 stock analysts who have covered BCPC. Price targets range from $175 at the low end to $206 at the high end. The current analyst consensus for BCPC is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 2 Wall Street analysts have assigned BCPC 2 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Balchem Corp to outperform the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on BCPC. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of BCPC.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $190 | Maintains | Nov 4, 2024 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $185 | Maintains | Jul 31, 2024 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $170 | Maintains | May 6, 2024 |
HC Wainwright & Co. | Buy | Maintains | Feb 20, 2024 | |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $135 | Maintains | Oct 30, 2023 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $165 | Maintains | Jul 31, 2023 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $150 | Maintains | Jun 5, 2023 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $140 | Maintains | Feb 27, 2023 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $152 | Maintains | Nov 7, 2022 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $164 | Maintains | Aug 22, 2022 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $152 | Maintains | May 2, 2022 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $155 | Maintains | Mar 8, 2022 |
Sidoti & Co. | Buy | Upgrade | Feb 22, 2022 | |
HC Wainwright & Co. | Buy | $170 | Maintains | Jan 10, 2022 |
Sidoti & Co. | Neutral | Downgrade | Nov 29, 2021 | |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $160 | Upgrade | Aug 2, 2021 |
| Mark Connelly Stephens & Co. | Equal-Weight | $145 | Downgrade | Aug 2, 2021 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $145 | Maintains | Feb 22, 2021 |
| Mark Connelly Stephens & Co. | Overweight | $140 | Upgrade | Feb 22, 2021 |
| Raghuram Selvaraju HC Wainwright & Co. | Buy | $126 | Maintains | Aug 4, 2020 |
When did it IPO
1986
Staff Count
1,300
Country
United States
Sector/Industry
Basic Materials/Specialty Chemicals
CEO
Mr. Theodore L. Harris
Market Cap
$5.84B
In 2023, BCPC generated $922.4M in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that BCPC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Thu, 21 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Blachem (BCPC) is identified as a potential opportunity for shorter-term investors due to its recent price trend and fundamental soundness, passing a trading strategy screen.
Why It Matters - Blachem's recent screening indicates strong fundamentals and positive price momentum, suggesting potential for short-term gains and attracting traders focused on timely opportunities.
Fri, 15 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Blachem (BCPC) and L.B. Foster (FSTR) have been compared to their sector's performance for the current year, indicating their relative market position. Further details were not provided.
Why It Matters - BCPC and FSTR's performance relative to their sector indicates potential market trends, competitive positioning, and investment opportunities within their industry.
Tue, 05 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Blachem (BCPC) is highlighted as a stock well-positioned to continue its recent uptrend, having passed the "Recent Price Strength" screening criteria.
Why It Matters - Blachem (BCPC) shows strong momentum, indicating potential for continued price appreciation, which may attract bullish investors seeking growth opportunities.
Fri, 01 Nov 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Balchem Corporation (NASDAQ: BCPC) will present at Baird's 54th Annual Global Industrial Conference on November 13, 2024.
Why It Matters - Balchem's presentation at a major conference may signal growth opportunities, attract investor interest, and influence stock performance in the health and nutrition sectors.
Fri, 01 Nov 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Blachem (BCPC) has been upgraded to a Zacks Rank #1 (Strong Buy), indicating positive earnings outlook and potential for stock price increase.
Why It Matters - Blachem's Zacks Rank #1 signals strong buy sentiment, indicating potential earnings growth, which could lead to a stock price increase and attract investor interest.
Wed, 30 Oct 2024
Sentiment - NEGATIVE
Source - Zacks Investment Research
Summary - Blachem (BCPC) and Barrick Gold (GOLD) performance compared to their sector has been reported for the year-to-date. Further details on their specific performance metrics are needed for analysis.
Why It Matters - Performance comparisons reveal relative strength or weakness within sectors, influencing investment choices and strategies. Investors may adjust portfolios based on this information.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
